Novartis expects the new capacity will allow it to produce all of its key medicines “end to end” in the U.S., as the Trump administration buffets global trade with tariffs.
Categories:
Related Post
Skanska intern builds on her interest in sustainable construction
Purdue engineering student Shivani Pemaraj, who also holds a black belt in karate, says she has…
Kiewit exec sees $1B opportunity in nuclear construction
Mike Rinehart, president of nuclear solutions at the firm, talks about the resurgence of nuclear…
Michigan creates mass timber program in construction adoption push
The state will offer money, guidance and technical assistance as demand increases for the alternative…